Cbd Synthase Pathway
CBD synthase is an enzyme that catalyzes the formation of cannabidiol (CBD) from cannabigerolic acid (CBGA) in cannabis plants. The pathway involves a specific genetic and biochemical process where CBGA is converted to either CBDA (which decarboxylates to CBD) or CBCA, depending on which synthase enzyme is expressed. Breeders distinguish this pathway from the THC synthase pathway, which produces THCA instead. The ratio of these two competing pathways is controlled by inherited genetic alleles, making it a primary target for breeding high-CBD cultivars. Understanding this enzymatic route has become foundational for modern cannabis breeding programs focused on non-intoxicating cannabinoid profiles.
Cbd Synthase Pathway strains
No strains tagged into Cbd Synthase Pathway yet — they'll appear here as breeders submit lineage records under this terpene.
CBD synthase is an enzyme that catalyzes the formation of cannabidiol (CBD) from cannabigerolic acid (CBGA) in cannabis plants. The pathway involves a specific genetic and biochemical process where CBGA is converted to either CBDA (which decarboxylates to CBD) or CBCA, depending on which synthase enzyme is expressed. Breeders distinguish this pathway from the THC synthase pathway, which produces THCA instead. The ratio of these two competing pathways is controlled by inherited genetic alleles, making it a primary target for breeding high-CBD cultivars. Understanding this enzymatic route has become foundational for modern cannabis breeding programs focused on non-intoxicating cannabinoid profiles.
Breeders select for CBD synthase-dominant genotypes by identifying and crossing plants with the recessive alleles that favor CBDA production over THCA. Marker-assisted selection and genetic testing now allow cultivators to reliably predict cannabinoid ratios before flowering, accelerating development of stable high-CBD lines.
Educational reference · Cultivar metadata only · No medical claims